-
This is the second approval this week for a generic version of Wellbutrin, earlier this week Watson Pharmaceuticals announced it’s new version. BD The Food and Drug Administration approved a generic copy of an antidepressant made by Impax Laboratories Inc. Regulators gave the drug — a copy of GlaxoSmithKline...
-
Teva Pharma has a generic version, but earlier this year there were some consumer complaints, now the FDA has cleared another manufacturer to produce a generic version, Watson Pharmaceuticals. This is for the 150 mg dose. No word yet as to the availability from the article. ...
-
The entire focus is to see whether or not patent laws have been violated and if less expensive generics were in any way stalled from getting to the market place. It all boils down to intellectual-property rights and patient disputes. Interesting that Teva is settling lawsuits and will be...
-
$9.99 for 90 days with enrollment with the Health Savings Pass CVS becomes the latest retail drug chain to jump on the bandwagon, pretty close in comparison, except you need to join the Health Savings Plan. The plan is primarily created for cash patients but anyone can benefit so if you have a...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-31-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, drugs, PHR, Google Health, Prescriptions, Generic Drugs, Personal Health Records, HealthVault, CVS, Discounts, Minute Clinic
-
I wonder if all the name brand companies will one day have nothing but generics? (grin). There’s always this interesting topic too, biosimilars. “Because biosimilars aren't exact duplicates of the original drugs, they don't violate the original drug's patent , enabling legal distribution...
-
As a physician, if you haven’t been marketed yet, you might expect some marketing efforts forthcoming soon. In Florida the insurance companies are offering free e-prescribing and I might guess by going through a clearinghouse that this will go directly into the records of one’s medications with...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-22-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, Other Items of Interest, Physician, healthcare, e-prescribing, HMO, e-Prescriptions, Generic Drugs, Patient, Pay for Performance
-
Medical Quack on Reuters. Now this is a sad state of affairs to be the prudent consumer, and yet you are potentially taking money out of your doctor's pocket by doing so when it comes to pay for performance for them, so what's up with this when purchasing $4.00 Generic Drugs. BD...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-18-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, My Commentaries, health insurance, Physicians, Pharma, HMO, Generic Drugs, Pay for Performance, Patients
-
The story keeps getting stranger by the day. A little recent history can be found here. The US is only 2-3% of their entire market so most pharmacies have already found other supplies, such as Walgreens did a few months ago when things started brewing. Will this soon be a Japanese...
-
More can be read here as well. The issue goes back to a raid in 2006 of a US warehouse in New Jersey. If the pills were a problem, why were they allowed to continue to ship with allegations that factory test records were falsified. Well I guess this now gives us the answer while the...
-
This brings up an interesting question, what do you go for relief or bankruptcy? Although now it is not real wide spread, but as the Biomed business continues to grow with new break throughs, how will this process continue? Is this more justification for biosimilars, the Biomed side of generic...
-
Digitek, as you may or may not remember was found to contain twice the amount of active ingredient in the tablets earlier this year. The list is below as published by the FDA. The recall is being conducted for retailers to return their products currently. It sounds like...
-
A new possible term in the world of Biotech, Biogenerics? We currently have Pharmacogenomics working and now perhaps an interest with the Generic Drug business investing in Biotech as well or perhaps the availability of a generic without a long patent protection period? I am not quite sure...
-
Good article from the Wall Street Journal blog here about generics, however in the example quoted below, the patient’s benefit payment of 146.53 just doesn’t come close to taking advantage of a cash prescription of the same drug for $10.00 for a 90 supply at Wal-Mart or Target . In this case with...
-
Teva also stated it plans to sue Novartis and Momenta for patent infringement. Recently in the news was the announcement to buy Bentley Pharmaceuticals. “Teva USA products are marketed to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies....
-
Congress and the Department of Justice now join the inquiry about the FDA actions investigating the alleged falsification of test records. This is where joint committees could also stand to shed some light here as both Australia and the UK are working with the FDA in reference to drug factories...